查看购物车
  • Traditional Chinese
  • English
  • Japanese
欧洲基因检测服务市场报告（2021-2031）范围、细分、动态和竞争分析
市场调查报告书
商品编码
1819730

欧洲基因检测服务市场报告（2021-2031）范围、细分、动态和竞争分析

Europe Genetic Testing Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 193 Pages | 订单完成后即时交付

价格

欧洲基因检测服务市场预计将大幅成长，到 2031 年将达到约 32.8496 亿美元，高于 2023 年的 10.4933 亿美元。这一成长代表着 2023 年至 2031 年的年复合成长率(CAGR) 为 15.3%。

执行摘要和市场分析

欧洲的基因检测服务市场主要分为几个主要区域，包括德国、英国、法国、义大利、西班牙和欧洲其他地区。基因检测需求激增，目前有各种不同的检测可用于筛检各种遗传疾病。许多罕见遗传疾病的治疗越来越便捷，基因检测在携带者检测、新生儿筛检以及预测性和症状前检测中的作用也越来越受到认可。欧洲各国已启动各种项目，以提高公众对基因检测优势的认识，旨在确保高品质标准，为患者提供准确可靠的结果。

市场区隔分析

基因检测服务市场可根据服务类型、疾病和服务提供者进行分类：

1. 服务类型：市场细分为预测检测、带因者检测、产前检测、新生儿筛检、诊断性基因检测等。 2023年，预测检测在市场占有率方面成为领先领域。

2. 疾病：市场也依疾病类型划分，包括癌症、心血管疾病、代谢失调和其他疾病。癌症领域在2023年占据了最大的市场份额，反映出肿瘤学对基因检测的需求很高。

3. 服务提供者：市场按服务提供者细分为医院实验室、诊断实验室和其他提供者。 2023年，医院实验室占据了最大的市场。

市场展望

个人化医疗领域正在快速发展，并被整合到各种医疗保健系统中。个人化医疗利用基因和环境资料，为个别患者提供个人化医疗服务。这种方法基于这样一种理念：每位患者都是独一无二的，可能需要特定的药物治疗。 2003年人类基因组计画（HGP）的完成，以及基因组定序成本的下降，为个人化医疗铺平了道路。专注于分子诊断的公司已做好准备，充分利用日益增长的分子层面个人化资料。

在德国，个人化医疗（简称个人化医疗，IM）已获得显着发展。德国联邦教育与研究部（BMBF）将个人化医疗列为2010年的优先发展领域，并启动了「个人化医疗」行动计画。此外，「十万人基因组计画」提升了国家医疗服务体系（NHS）作为领先医疗体系的声誉，进一步支持了基因检测服务市场的成长。法国也透过「法国基因组医学2025」计画在这一领域取得了进展，该计画旨在透过大量公共投资，使法国成为基因组医学领域的领导者。

药物研发的进步对于提高个人化医疗在疾病诊断中的有效性至关重要。基因组学正迅速成为医学科学的关键领域，彻底改变了疾病诊断和治疗的研究方法。基因检测在药物基因组学中发挥着至关重要的作用，它加速了药物的研发进程。

国家洞察

欧洲基因检测服务市场主要包括英国、德国、法国、义大利、西班牙等国家。 2023年，德国占据了最大的市场份额。医学遗传学已成为临床实践不可或缺的一部分，为医疗专业人员提供了管理疾病和实施预防措施的宝贵诊断工具。 2022年发表的一项研究强调，德国约有400万人患有罕见疾病。罕见疾病的日益流行，加上专用检测试剂盒的开发，正在推动市场成长。例如，2020年，德国报告了约69,697例新的乳癌病例，占所有癌症病例的11.1%，其中很大一部分病例与BRCA突变有关。

德国政府已采取措施，将BRCA基因检测纳入国家癌症策略，加强高遗传风险女性的筛检和风险降低方案。 2022年，非侵入性产前检测将作为公共报销服务引入，进一步彰显了德国促进基因检测发展的决心。政府倡议、消费者意识的提升以及医疗保健支出的增加等因素预计将推动德国市场的成长。

公司简介

欧洲基因检测服务市场的主要参与者包括 Eurofins Scientific SE、Exact Sciences Corp、Laboratory Corp of America Holdings、23andMe Holding Co、Ambry Genetics Corp、Quest Diagnostics Inc、Illumina Inc、F. Hoffmann-La Roche Ltd、NeoGenomics Inc、Cento NV Inc、VERITAS INTERCONTINENTAL 和 GeneDx, LLC。这些公司正在采用各种策略，包括扩张、产品创新和併购，以增强其市场影响力并为消费者提供创新解决方案。

目录

第一章：简介

第 2 章：执行摘要

  • 关键见解

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：欧洲基因检测服务市场格局

  • PEST分析

第五章：欧洲基因检测服务市场-主要市场动态

  • 市场驱动因素
    • 遗传疾病盛行率上升
    • 提高对个人化医疗的认识和接受度
    • 消费者对直接面向消费者（DTC）基因检测的偏好日益增长
  • 市场限制
    • 基因检测的社会和伦理影响
    • 基因服务的可负担性
  • 市场机会
    • 监管支持
  • 未来趋势
    • 人工智慧基因检测
  • 影响分析：

第六章：欧洲基因检测服务市场分析

  • 2021-2031年欧洲基因检测服务市场收入
  • 欧洲基因检测服务市场预测分析

第七章：欧洲基因检测服务市场分析－依服务类型

  • 预测测试
  • 携带者检测
  • 产前检查
  • 新生儿筛检
  • 诊断性基因检测
  • 其他的

第八章：欧洲基因检测服务市场分析－按疾病

  • 癌症
  • 心血管疾病
  • 代谢性疾病
  • 其他疾病

第九章：欧洲基因检测服务市场分析－依最终用户

  • 医院实验室
  • 诊断实验室
  • 其他最终用户

第 10 章：欧洲基因检测服务市场-国家分析

  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区

第 11 章：基因检测服务市场-产业格局

  • 概述
  • 基因检测服务市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Eurofins Scientific SE
  • Exact Sciences Corp
  • Laboratory Corp of America Holdings
  • andMe Holding Co
  • Ambry Genetics Corp
  • Quest Diagnostics Inc
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • NeoGenomics Inc
  • Centogene NV
  • Ancestry Genomics Inc
  • Gene By Gene Ltd
  • SIVOTEC BioInformatics LLC
  • Progenesis
  • Fulgent Genetics, Inc
  • VERITAS INTERCONTINENTAL
  • GeneDx, LLC

第 13 章：附录

Product Code: TIPRE00009240

The European genetic testing services market is projected to grow significantly, reaching approximately USD 3,284.96 million by 2031, up from USD 1,049.33 million in 2023. This growth represents a compound annual growth rate (CAGR) of 15.3% from 2023 to 2031.

Executive Summary and Market Analysis

The market for genetic testing services in Europe is divided into several key regions, including Germany, the UK, France, Italy, Spain, and the Rest of Europe. The demand for genetic testing has surged, with a wide array of tests now available to screen for various genetic disorders. Treatments for numerous rare genetic conditions are becoming more accessible, and genetic testing is increasingly recognized for its role in carrier testing, newborn screening, and predictive and pre-symptomatic testing. European nations have initiated various programs to enhance public awareness regarding the advantages of genetic testing, aiming to ensure high-quality standards that yield accurate and reliable results for patients.

Market Segmentation Analysis

The genetic testing services market can be categorized based on service type, disease, and service provider:

1. Service Type: The market is segmented into predictive testing, carrier testing, prenatal testing, newborn screening, diagnostic genetic testing, and others. In 2023, predictive testing emerged as the leading segment in terms of market share.

2. Disease: The market is also divided by disease type, including cancer, cardiovascular diseases, metabolic disorders, and other conditions. The cancer segment held the largest market share in 2023, reflecting the high demand for genetic testing in oncology.

3. Service Provider: The market is segmented by service provider into hospital-based laboratories, diagnostic laboratories, and other providers. Hospital-based laboratories accounted for the largest share of the market in 2023.

Market Outlook

The field of personalized medicine, which leverages genetic and environmental data to tailor healthcare to individual patients, is rapidly evolving and being integrated into various healthcare systems. This approach is grounded in the understanding that each patient is unique and may require specific pharmacological treatments. The completion of the Human Genome Project (HGP) in 2003, along with the decreasing costs of genome sequencing, has paved the way for personalized medicine. Companies specializing in molecular diagnostics are well-positioned to capitalize on the growing repository of personalized data at the molecular level.

In Germany, personalized medicine, referred to as individualized medicine (IM), has gained significant traction. The German Federal Ministry of Education and Research (BMBF) identified personalized medicine as a priority area by 2010, launching the "Individualized Medicine" Action Plan. Additionally, the 100,000 Genomes Project has bolstered the National Health Service's reputation as a leading healthcare system, further supporting the growth of the genetic testing services market. France has also made strides in this area with its "Genomic Medicine France 2025" initiative, which aims to position the country as a leader in genomic medicine through substantial public investment.

The advancement of drug discovery is crucial for enhancing the effectiveness of personalized medicines in diagnosing diseases. Genomics is rapidly becoming a pivotal area in medical science, transforming research methodologies for disease diagnosis and treatment. Genetic testing plays a vital role in pharmacogenomics, which accelerates drug discovery and development processes.

Country Insights

The European genetic testing services market includes key countries such as the UK, Germany, France, Italy, Spain, and others. Germany held the largest market share in 2023. Medical genetics has become integral to clinical practice, providing healthcare professionals with valuable diagnostic tools for managing diseases and implementing preventive measures. A study published in 2022 highlighted that rare diseases affect around four million individuals in Germany. The increasing prevalence of rare diseases, coupled with the development of specialized testing kits, is driving market growth. For instance, in 2020, Germany reported approximately 69,697 new breast cancer cases, accounting for 11.1% of all cancer cases, with a significant portion of these cases linked to BRCA mutations.

The German government has taken steps to include BRCA genetic testing in its national cancer strategy, enhancing screening and risk-reduction options for women at high genetic risk. The introduction of noninvasive prenatal testing as a publicly reimbursed service in 2022 further illustrates the country's commitment to advancing genetic testing. Factors such as government initiatives, rising consumer awareness, and increased healthcare spending are expected to propel market growth in Germany.

Company Profiles

Key players in the European genetic testing services market include Eurofins Scientific SE, Exact Sciences Corp, Laboratory Corp of America Holdings, 23andMe Holding Co, Ambry Genetics Corp, Quest Diagnostics Inc, Illumina Inc, F. Hoffmann-La Roche Ltd, NeoGenomics Inc, Centogene NV, Ancestry Genomics Inc, Gene By Gene Ltd, SIVOTEC BioInformatics LLC, Progenesis, Fulgent Genetics, Inc, VERITAS INTERCONTINENTAL, and GeneDx, LLC. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to consumers.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. Europe Genetic Testing Services Market Landscape

  • 4.1 PEST Analysis

5. Europe Genetic Testing Services Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Genetic Diseases
    • 5.1.2 Increasing Awareness and Acceptance of Personalized Medicines
    • 5.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
  • 5.2 Market Restraints
    • 5.2.1 Social and Ethical Implications of Genetic Testing
    • 5.2.2 Affordability of Genetic Services
  • 5.3 Market Opportunities
    • 5.3.1 Regulatory Support
  • 5.4 Future Trends
    • 5.4.1 Artificial Intelligence-Powered Genetic Testing
  • 5.5 Impact Analysis:

6. Genetic Testing Services Market - Europe Analysis

  • 6.1 Europe Genetic Testing Services Market Revenue (US$ Million), 2021-2031
  • 6.2 Europe Genetic Testing Services Market Forecast Analysis

7. Europe Genetic Testing Services Market Analysis - by Service Type

  • 7.1 Predictive Testing
    • 7.1.1 Overview
    • 7.1.2 Predictive Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Carrier Testing
    • 7.2.1 Overview
    • 7.2.2 Carrier Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Prenatal Testing
    • 7.3.1 Overview
    • 7.3.2 Prenatal Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 New-born Screening
    • 7.4.1 Overview
    • 7.4.2 New-born Screening: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Diagnostic Genetic Testing
    • 7.5.1 Overview
    • 7.5.2 Diagnostic Genetic Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Genetic Testing Services Market Analysis - by Disease

  • 8.1 Cancer
    • 8.1.1 Overview
    • 8.1.2 Cancer: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Cardiovascular Diseases
    • 8.2.1 Overview
    • 8.2.2 Cardiovascular Diseases: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Metabolic Diseases
    • 8.3.1 Overview
    • 8.3.2 Metabolic Diseases: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Other Diseases
    • 8.4.1 Overview
    • 8.4.2 Other Diseases: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Genetic Testing Services Market Analysis - by End User

  • 9.1 Hospital-Based Laboratories
    • 9.1.1 Overview
    • 9.1.2 Hospital-Based Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Diagnostic Laboratories
    • 9.2.1 Overview
    • 9.2.2 Diagnostic Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Other End User
    • 9.3.1 Overview
    • 9.3.2 Other End User: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Genetic Testing Services Market - Country Analysis

  • 10.1 Europe
    • 10.1.1 Europe Genetic Testing Services Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 Europe Genetic Testing Services Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 United Kingdom: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 United Kingdom: Europe Genetic Testing Services Market Share - by Service Type
        • 10.1.1.2.2 United Kingdom: Europe Genetic Testing Services Market Share - by Disease
        • 10.1.1.2.3 United Kingdom: Europe Genetic Testing Services Market Share - by Cancer Disease
        • 10.1.1.2.4 United Kingdom: Europe Genetic Testing Services Market Share - by End User
      • 10.1.1.3 Germany: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Germany: Europe Genetic Testing Services Market Share - by Service Type
        • 10.1.1.3.2 Germany: Europe Genetic Testing Services Market Share - by Disease
        • 10.1.1.3.3 Germany: Europe Genetic Testing Services Market Share - by Cancer Disease
        • 10.1.1.3.4 Germany: Europe Genetic Testing Services Market Share - by End User
      • 10.1.1.4 France: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 France: Europe Genetic Testing Services Market Share - by Service Type
        • 10.1.1.4.2 France: Europe Genetic Testing Services Market Share - by Disease
        • 10.1.1.4.3 France: Europe Genetic Testing Services Market Share - by Cancer Disease
        • 10.1.1.4.4 France: Europe Genetic Testing Services Market Share - by End User
      • 10.1.1.5 Spain: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.5.1 Spain: Europe Genetic Testing Services Market Share - by Service Type
        • 10.1.1.5.2 Spain: Europe Genetic Testing Services Market Share - by Disease
        • 10.1.1.5.3 Spain: Europe Genetic Testing Services Market Share - by Cancer Disease
        • 10.1.1.5.4 Spain: Europe Genetic Testing Services Market Share - by End User
      • 10.1.1.6 Italy: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.6.1 Italy: Europe Genetic Testing Services Market Share - by Service Type
        • 10.1.1.6.2 Italy: Europe Genetic Testing Services Market Share - by Disease
        • 10.1.1.6.3 Italy: Europe Genetic Testing Services Market Share - by Cancer Disease
        • 10.1.1.6.4 Italy: Europe Genetic Testing Services Market Share - by End User
      • 10.1.1.7 Rest of Europe: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.7.1 Rest of Europe: Europe Genetic Testing Services Market Share - by Service Type
        • 10.1.1.7.2 Rest of Europe: Europe Genetic Testing Services Market Share - by Disease
        • 10.1.1.7.3 Rest of Europe: Europe Genetic Testing Services Market Share - by Cancer Disease
        • 10.1.1.7.4 Rest of Europe: Europe Genetic Testing Services Market Share - by End User

11. Genetic Testing Services Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Genetic Testing Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Eurofins Scientific SE
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Exact Sciences Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Laboratory Corp of America Holdings
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4andMe Holding Co
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Ambry Genetics Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Quest Diagnostics Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Illumina Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 F. Hoffmann-La Roche Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 NeoGenomics Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Centogene NV
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Ancestry Genomics Inc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Gene By Gene Ltd
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 SIVOTEC BioInformatics LLC
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 Progenesis
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 Fulgent Genetics, Inc
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Products and Services
    • 12.15.4 Financial Overview
    • 12.15.5 SWOT Analysis
    • 12.15.6 Key Developments
  • 12.16 VERITAS INTERCONTINENTAL
    • 12.16.1 Business Description
    • 12.16.2 Products and Services
    • 12.16.3 Financial Overview
    • 12.16.4 SWOT Analysis
    • 12.16.5 Key Developments
  • 12.17 GeneDx, LLC
    • 12.17.1 Key Facts
    • 12.17.2 Business Description
    • 12.17.3 Products and Services
    • 12.17.4 Financial Overview
    • 12.17.5 SWOT Analysis
    • 12.17.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Genetic Testing Services Market Segmentation
  • Table 2. Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Type
  • Table 4. Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Disease
  • Table 5. Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 6. Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. United Kingdom: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 8. United Kingdom: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 9. United Kingdom: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 10. United Kingdom: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 11. Germany: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 12. Germany: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 13. Germany: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 14. Germany: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 15. France: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 16. France: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 17. France: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 18. France: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 19. Spain: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 20. Spain: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 21. Spain: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 22. Spain: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 23. Italy: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 24. Italy: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 25. Italy: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 26. Italy: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 27. Rest of Europe: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 28. Rest of Europe: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 29. Rest of Europe: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 30. Rest of Europe: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 31. Recent Organic Growth Strategies in Genetic Testing Services Market
  • Table 32. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
  • Table 33. Glossary of Terms, Genetic Testing Services Market

List Of Figures

  • Figure 1. Europe Genetic Testing Services Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Europe Genetic Testing Services Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Europe Genetic Testing Services Market Revenue (US$ Million), 2021-2031
  • Figure 6. Europe Genetic Testing Services Market Share (%) - by Service Type (2023 and 2031)
  • Figure 7. Predictive Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Carrier Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Prenatal Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. New-born Screening: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Diagnostic Genetic Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Others: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Europe Genetic Testing Services Market Share (%) - by Disease (2023 and 2031)
  • Figure 14. Cancer: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Cardiovascular Diseases: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Metabolic Diseases: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Other Diseases: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Europe Genetic Testing Services Market Share (%) - by End User (2023 and 2031)
  • Figure 19. Hospital-Based Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Diagnostic Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Other End User: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 22. Europe Genetic Testing Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 23. United Kingdom: Europe Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Germany: Europe Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. France: Europe Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Spain: Europe Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. Italy: Europe Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 28. Rest of Europe: Europe Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 29. Growth Strategies in Genetic Testing Services Market